| 000 | 00976 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517224248.0 | ||
| 264 | 0 | _c20200323 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1468-2060 | ||
| 024 | 7 |
_a10.1136/annrheumdis-2018-213866 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoura, Carlos Antonio | |
| 245 | 0 | 0 |
_aCheckpoint inhibitors and arthritis: seeking balance between victories and defeats. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _c09 2019 |
||
| 300 |
_ae91 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAntirheumatic Agents |
| 650 | 0 | 4 | _aArthritis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasms |
| 650 | 0 | 4 | _aPolymyalgia Rheumatica |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aMoura, Carlos Geraldo | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 78 _gno. 9 _gp. e91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/annrheumdis-2018-213866 _zAvailable from publisher's website |
| 999 |
_c28576969 _d28576969 |
||